SPONSOR
St. Jude Children's Research Hospital
Total Trials
12
Recruiting
12
Phases
Phase 2, Phase 1, Phase 1, Phase 2, EARLY_Phase 1
Conditions studied: Pediatric Solid TumorsNeuroblastoma RecurrentRefractory Acute Myeloid LeukemiaRelapsed Acute Myeloid LeukemiaAcute Leukemia of Ambiguous LineageAdipocytic NeoplasmLiposarcomaAtypical FibroxanthomaAngiomatoid Fibrous HistiocytomaMyoepithelioma
St. Jude Children's Research Hospital is a clinical research sponsor with 12 registered studies on ClinicalTrials.gov, of which 12 are actively recruiting participants. Research covers conditions including Pediatric Solid Tumors, Neuroblastoma Recurrent, Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia.
The trial portfolio spans Phase 2, Phase 1, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — St. Jude Children's Research Hospital
How many clinical trials has St. Jude Children's Research Hospital sponsored?
ClinicalMetric currently tracks 12 clinical trials sponsored by St. Jude Children's Research Hospital, of which 12 are actively recruiting participants. These trials cover conditions including Pediatric Solid Tumors, Neuroblastoma Recurrent, Refractory Acute Myeloid Leukemia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does St. Jude Children's Research Hospital research focus on?
St. Jude Children's Research Hospital clinical trials span Pediatric Solid Tumors, Neuroblastoma Recurrent, Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Acute Leukemia of Ambiguous Lineage, and additional conditions. The research pipeline includes Phase 2, Phase 1, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a St. Jude Children's Research Hospital clinical trial?
To participate in a St. Jude Children's Research Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all St. Jude Children's Research Hospital trials with current recruitment status updated daily.
Clinical Trials by St. Jude Children's Research Hospital
NCT01050296
Recruiting
Molecular Analysis Of Solid Tumors
Pediatric Solid Tumors
NCT07085338 Phase 2
Recruiting
A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma
Neuroblastoma Recurrent
NCT06177067 Phase 1
Recruiting
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
Refractory Acute Myeloid Leukemia
NCT06239272 Phase 1, Phase 2
Recruiting
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
Adipocytic Neoplasm
NCT07226219 Phase 1
Recruiting
Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease
Sickle Cell Disease
NCT04901702 Phase 1, Phase 2
Recruiting
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Recurrent Solid Tumor
NCT07110519 EARLY_Phase 1
Recruiting
Positron Emission Tomography (PET) Contrast Agent Kinetics and Safety: [18F]-Fluoromannitol
Healthy
NCT05664126 Phase 2
Recruiting
Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation
Cytomegalovirus
NCT06477289
Recruiting
Peripheral Arterial Tonometry and Neurocognition in Sickle Cell Disease
Sickle Cell Disease
NCT03050268
Recruiting
Familial Investigations of Childhood Cancer Predisposition
Acute Leukemia
NCT07245420
Recruiting
Evaluation Of Cardiovascular Health Outcomes Among Survivors 2
Health Behavior
NCT07222735 Phase 1
Recruiting
Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas
Sarcoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology